New push to control cancer before curing it
UK centre focuses efforts to manage the disease in the same way as HIV
17th May 2019
UK cancer researchers are launching what they call the world's first "Darwinian" drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments.
While not abandoning the search for an ultimate cure, the "anti-evolution" project will refocus on turning cancer into a disease controllable with drugs for many years.
This would be a little like HIV, the scientists told reporters at a briefing.
"Cancer's ability to adapt, evolve and become drug-resistant is the cause of the vast majority of deaths
